Thomson Reuters Corp (TRI.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Thomson Reuters Corp (TRI.TO)

142.68

-4.97 (3.37%)

as of Aug 14, 2026, 3:02:42 pm Market Open.

221 watching

Investor Insights

Aug 13, 2026, 12:00 am

This summary was created by AI, based on 37 opinions in the last 12 months.

Thomson Reuters Corp (TRI-T) is experiencing a mix of skepticism and optimism driven by fears surrounding AI's potential impact on its services, particularly in the legal and accounting sectors. Despite these concerns, many analysts believe TRI’s proprietary data and established market position provide some insulation against AI disruption. The company recently reported solid earnings growth and is investing in share buybacks, indicating confidence in its future. Several experts view the current valuation as more attractive than before and see opportunities for long-term growth, while caution still exists due to valuation discussions and market sentiment. The firm's traditional business model continues to be seen as viable, and many believe it's well-positioned to integrate AI into its offerings, potentially enhancing its competitive advantage.

Consensus

Buy

Valuation

Undervalued

Similar

TMX,TMX

BUY

A defensive holding. Had a nice pop over the last 2-3 months and the market is getting little more comfortable with the name. Expects the company to grow at about 12% on a year-over-year basis. Reasonable dividend yield.

DON'T BUY

His model price is going up indicating that the business fundamentals are going up. Unfortunately, his model price of $41.40 is underneath the stock price of $50. A negative 16% differential.

TOP PICK

A great defensive company. Recently sold its learning division. Well positioned in the global economy to benefit from the increasing use of technology to access information. Not exposed to the consumer.

BUY

Likes this company a lot. There has been gradually improving margins and asset turnover. Has a 95% probability that it outperforms the market.

TOP PICK

(A Top Pick Feb 14/06. Up 10.3%.) Looks at this as an information conglomerate and he likes conglomerates. The stock had formed a rounded base last year and broke out in the latter part. Under owned.

HOLD

A high-quality Canadian company that always enjoys really rich multiples. Shares are fully valued at this time.

PAST TOP PICK

(A Top Pick Oct 18/06. Up 6.1%.) Particularly likes this going into a slowing economy, because they sell information that people need.

DON'T BUY

Have been making a few acquisitions. Trades at a healthy price/earnings ratio.

SELL

There are better places to put your money.

BUY

Re-focusing and selling some pieces in order to be an e-business. Looking at 8% to 12% growth. High quality and pays a dividend.

DON'T BUY

This is a great company, but thinks the stock will continue to go sideways. Growth rate is rather anaemic and the multiple is extremely high.

BUY

Unloading their Learning Division for $5 billion. Likes their focus on new management.

TOP PICK

A very defensive company but has solid growth. Organic growth of 7 to 9%. Likely to increase the dividend at a 10% annual rate. In none economic sensitive areas.

TOP PICK

Starting to make substantial moves into engineering, sciences, etc besides their current legal and medical areas. Have been investing their capital into the new areas and it is starting to show results. Seeing consistent increases in revenues. ROE has been improving quarter after quarter.

DON'T BUY

Trades at a fairly lofty multiple. Showing modest growth. Trading on the more expensive side.

Showing 466 to 480 of 718 entries

Most Recent Experts

Stan Wong

Private Wealth Management, ScotiaMcleod

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Chris Blumas

at Raymond James Investment Counsel Ltd.

Shannon Saccocia, CIO, Boston Private

Boston Private

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Thomson Reuters Corp (TRI.TO)